Staging System of the Veterans Administration Lung Cancer Study Group (VALCSG) for Small Cell Lung Carcinoma (Limited versus Extensive Stage Disease)

Description

The Veterans Administration (VA) Lung Study Group divided patients with small cell lung cancer (SCLC) into limited and extensive stages.

Patient selection: small cell lung cancer

The primary measure was the size of one tolerable radiotherapy portal, with localized disease fitting into 1 and extensive disease requiring more than 1.

Stage

Hemithorax Involved

Other Findings

limited (LS)

lymph nodes within radiation portal

(ipsilateral hilar, mediastinal and/or supraclavicular; contralateral hilar)

extensive (ES)

> 1 OR metastatic

malignant pleural or pericardial effusion; lymph nodes outside of radiation portal

Stage	Median Overall Survival	5-Year Survival
limited	20 months	15-20%
extensive	8 to 12 months	less than 2%

To read more or access our algorithms and calculators, please log in or register.

Description

Specialty

ICD-10